169 related articles for article (PubMed ID: 16164152)
1. The role of the vehicle in combination acne therapy.
Del Rosso JQ
Cutis; 2005 Aug; 76(2 Suppl):15-8. PubMed ID: 16164152
[TBL] [Abstract][Full Text] [Related]
2. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid.
Del Rosso JQ; Tanghetti E
J Drugs Dermatol; 2006 Feb; 5(2):160-4. PubMed ID: 16485884
[TBL] [Abstract][Full Text] [Related]
4. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
5. Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris.
Ochsendorf F
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 5():8-13. PubMed ID: 26059820
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S; Gold M; Nasir A; Vamvakias G
J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
[TBL] [Abstract][Full Text] [Related]
7. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
Kircik L
Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581
[TBL] [Abstract][Full Text] [Related]
8. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
9. Evaluating tretinoin formulations in the treatment of acne.
Kircik LH
J Drugs Dermatol; 2014 Apr; 13(4):466-70. PubMed ID: 24719067
[TBL] [Abstract][Full Text] [Related]
10. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years.
Eichenfield LF; Wortzman M
Pediatr Dermatol; 2009; 26(3):257-61. PubMed ID: 19706084
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS
Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
[TBL] [Abstract][Full Text] [Related]
12. Reduced skin irritation with tretinoin containing polyolprepolymer-2, a new topical tretinoin delivery system: a summary of preclinical and clinical investigations.
Quigley JW; Bucks DA
J Am Acad Dermatol; 1998 Apr; 38(4):S5-10. PubMed ID: 9555820
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of micronized tretinoin gel (0.05%) in treating adolescent acne.
Torok HM; Pillai R
J Drugs Dermatol; 2011 Jun; 10(6):647-52. PubMed ID: 21637905
[TBL] [Abstract][Full Text] [Related]
14. Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
Bikowski J; Del Rosso JQ
J Drugs Dermatol; 2008 Jun; 7(6):590-5. PubMed ID: 18561594
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris.
Ellis CN; Leyden J; Katz HI; Goldfarb MT; Hickman J; Jones TM; Tschen E
Cutis; 2001 Feb; 67(2 Suppl):13-20. PubMed ID: 11236210
[TBL] [Abstract][Full Text] [Related]
16. A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults.
Berger R; Barba A; Fleischer A; Leyden JJ; Lucky A; Pariser D; Rafal E; Thiboutot D; Wilson D; Grossman R; Nighland M
Cutis; 2007 Aug; 80(2):152-7. PubMed ID: 17944177
[TBL] [Abstract][Full Text] [Related]
17. Advances in topical delivery systems in acne: new solutions to address concentration dependent irritation and dryness.
Ceilley RI
Skinmed; 2011; 9(1):15-21. PubMed ID: 21409958
[TBL] [Abstract][Full Text] [Related]
18. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
Tanghetti E
Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of tretinoin gel microsphere, 0.1%, versus tretinoin cream, 0.025%, in reducing facial shine.
Nyirady J; Nighland M; Payonk G; Pote J; Phillips S; Grossman R
Cutis; 2000 Aug; 66(2):153-6. PubMed ID: 10955199
[TBL] [Abstract][Full Text] [Related]
20. Tretinoin microsphere gel in younger acne patients.
Jorizzo J; Grossman R; Nighland M
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s9-13. PubMed ID: 18724649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
